Your browser doesn't support javascript.
loading
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.
Mehta, Rohtesh S; Holtan, Shernan G; Wang, Tao; Hemmer, Michael T; Spellman, Stephen R; Arora, Mukta; Couriel, Daniel R; Alousi, Amin M; Pidala, Joseph; Abdel-Azim, Hisham; Agrawal, Vaibhav; Ahmed, Ibrahim; Al-Homsi, A Samer; Aljurf, Mahmoud; Antin, Joseph H; Askar, Medhat; Auletta, Jeffery J; Bhatt, Vijaya Raj; Chee, Lynette; Chhabra, Saurabh; Daly, Andrew; DeFilipp, Zachariah; Gajewski, James; Gale, Robert Peter; Gergis, Usama; Hematti, Peiman; Hildebrandt, Gerhard C; Hogan, William J; Inamoto, Yoshihiro; Martino, Rodrigo; Majhail, Navneet S; Marks, David I; Nishihori, Taiga; Olsson, Richard F; Pawarode, Attaphol; Diaz, Miguel Angel; Prestidge, Tim; Rangarajan, Hemalatha G; Ringden, Olle; Saad, Ayman; Savani, Bipin N; Schoemans, Hélène; Seo, Sachiko; Schultz, Kirk R; Solh, Melhem; Spitzer, Thomas; Storek, Jan; Teshima, Takanori; Verdonck, Leo F; Wirk, Baldeep.
Afiliação
  • Mehta RS; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Holtan SG; University of Minnesota, Minneapolis, MN.
  • Wang T; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI.
  • Hemmer MT; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Spellman SR; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI.
  • Arora M; CIBMTR, National Marrow Donor Program/Be the Match, Minneapolis, MN.
  • Couriel DR; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN.
  • Alousi AM; Utah Blood and Marrow Transplant Program, Salt Lake City, UT.
  • Pidala J; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Abdel-Azim H; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Agrawal V; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA.
  • Ahmed I; Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN.
  • Al-Homsi AS; Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO.
  • Aljurf M; New York University Langone Medical Center, New York, NY.
  • Antin JH; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Askar M; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Auletta JJ; Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, TX.
  • Bhatt VR; Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH.
  • Chee L; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
  • Chhabra S; Royal Melbourne Hospital City Campus, Victoria, Australia.
  • Daly A; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • DeFilipp Z; Tom Baker Cancer Center, Calgary, Alberta, Canada.
  • Gajewski J; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA.
  • Gale RP; Oregon Health and Science University, Portland, OR.
  • Gergis U; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Hematti P; Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
  • Hildebrandt GC; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI.
  • Hogan WJ; Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Inamoto Y; Division of Hematology/Bone Marrow Transplantation, Mayo Clinic, Rochester, MN.
  • Martino R; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Majhail NS; Division of Clinical Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Marks DI; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Nishihori T; Adult Bone Marrow Transplant, University Hospitals Bristol National Health Service Trust, Bristol, United Kingdom.
  • Olsson RF; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Pawarode A; Translational Cell Therapy Research, Clintec, Karolinska Institutet, Stockholm, Sweden.
  • Diaz MA; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Prestidge T; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI.
  • Rangarajan HG; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Ringden O; Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
  • Saad A; Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH.
  • Savani BN; Translational Cell Therapy Research, Clintec, Karolinska Institutet, Stockholm, Sweden.
  • Schoemans H; Division of Hematology, Ohio State University, Columbus, OH.
  • Seo S; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
  • Schultz KR; University Hospital Leuven and Katholieke Universiteit Leuven, Leuven, Belgium.
  • Solh M; Department of Hematology & Oncology, National Cancer Research Center East, Chiba, Japan.
  • Spitzer T; Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
  • Storek J; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA.
  • Teshima T; Tom Baker Cancer Center, Calgary, Alberta, Canada.
  • Verdonck LF; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Wirk B; Hokkaido University Hospital, Sapporo, Japan.
J Clin Oncol ; 38(18): 2062-2076, 2020 06 20.
Article em En | MEDLINE | ID: mdl-32364845
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article